[121]
Effect of Smoking Reduction on Lung Cancer Risk
[50,4 KB]
From [www.ministerosalute.it] Last viewed: 07.09.2006
Select Journal or Resource
Vol. 294 No. 12, September 28, 2005
Featured Link
• E-mail Alerts
Original Contribution
Effect of Smoking Reduction on Lung Cancer Risk
Nina S. Godtfredsen, MD, PhD; Eva Prescott, MD, DMSc; Merete Osler, MD, PhD, DMSc
JAMA. 2005;294:1505-1510.
Context Many smokers are unable or unwilling to completely quit smoking. A proposed means of harm reduction is to
reduce the number of cigarettes smoked per day. However, it is not clear whether this strategy decreases the risk for
tobacco-related diseases.
Objective To assess the effects of smoking reduction on lung cancer incidence.
Design, Setting, and Participants Observational population-based cohort study with up to 31 years of follow-up
from the Copenhagen Centre for Prospective Population Studies, which administrates data from 3 longitudinal studies
conducted in Copenhagen and suburbs, ...
[122]
Lung Cancer Snapshot.indd
[2669,7 KB]
From [planning.cancer.gov] Last viewed: 07.09.2006
Incidence and Mortality
Rate Trends
Lung cancer is the second most common cancer
and the most common cause of cancer -related
death in both men and women in the United
States. The overall mortality rate for lung and
bronchus cancer rose steadily through the 1980s
and peaked around 1990. While incidence and
mortality rates for men have dropped in the
last decade, this trend has not been observed
for women. Mortality rates are highest among
African American males, followed by White
males.
It is estimated that approximately $9.6 billion* is
spent in the United States each year on treatment
of lung cancer .
*In 2004 dollars, as reported in Brown ML, Riley GF,
Schussler N, and Etzioni RD. Estimating health care costs
related to cancer treatment from SEER-Medicare data.
Medical Care 2002 Aug; 40 (8 Suppl): IV-104-17.
Source for incidence ...
[123]
9495.02 NCCN Lung Cancer Treatment Guidelines
[802,1 KB]
From [www.nccn.org] Last viewed: 07.09.2006
888 16th Street NW
Suite 800
Washington DC 20006
202-463-2080
800-298-2436 hotline
lungcanceralliance.org
NO MORE EXCUSES. NO MORE LUNG CANCER .
Lung cancer is the leading cause of cancer death in the
United States.
Lung cancer causes 30% of all cancer deaths.
Lung cancer is the leading cancer killer among Caucasians,
African-Americans, Asians and Hispanic males.
Lung cancer will kill more people this year than:
• breast cancer
• prostate cancer
• colon cancer
• liver cancer
• kidney cancer
• melanoma combined
Lung cancer will kill 3 times as many men as prostate
cancer this year.
Lung cancer will kill nearly twice as many women as breast
cancer this year.
Over 50% of new lung cancer cases will be diagnosed at a
very late stage—Stage IIIb or IV—and only 5% of them will ...
[124]
LUNG CANCER ALLIANCE TAKES LANDMARK ACTION; SEEKS LUNG CANCER ...
[55,5 KB]
From [www.alcase.org] Last viewed: 07.09.2006
September 2, 2005
LUNG CANCER ALLIANCE TAKES LANDMARK ACTION;
SEEKS LUNG CANCER RESEARCH AND EARLY DETECTION FUND
FROM TOBACCO INDUSTRY
The Lung Cancer Alliance (LCA) took landmark action today by requesting leave to file an
Amicus Brief before the United States District Court to add lung cancer research and early
detection to the remedies that the court is considering in the case of the United States of
America vs. Philip Morris, USA, Inc and other tobacco companies.
The court is currently considering only funding for tobacco control and smoking cessation
programs as remedies to prevent and restrain future wrongdoing by the tobacco company
defendants. In the brief, LCA argues that in addition to these remedies, the defendants should
be required to contribute to a fund to support independent scientific research on the aetiology,
diagnosis, treatment and cure of lung cancer ...
[125]
Specifications: • No. of cases: 6 • Tissue type: Test slide, lung ...
[82,8 KB]
From [www.arrayit.com] Last viewed: 07.09.2006
(formalin fixed)
A716: Test slide - Lung cancer tissues with
corresponding normal tissues
For research use only
Specifications:
• No. of cases: 6
• Tissue type: Test slide, lung cancer tissues with corresponding
normal tissues
• No. of spots: 1 spot from each cancer case (6 spots)
6 non-neoplastic spots (6 spots)
• Total spots: 12
• Corresponding normal tissues with cancers: Yes
• Diameter: 1. 0 mm
Documents :
• Product specification: layout, summary of tissue spots
• H&E stained images
• Detailed pathological information
Layout:
Page 2
(formalin fixed)
A716: Test slide - Lung cancer tissues with
corresponding normal tissues
For research use only
Summary of tissue spots
No. Coordinate
Sex
Age
Organ
KeyWord
1
...
[126]
The Australian Lung Foundation / Lung Cancer Consultative Group ...
[408,4 KB]
From [www.thoracic.org.au] Last viewed: 07.09.2006
The Australian Lung Foundation / Lung Cancer Consultative Group
Travel Awards
Four travel awards in the amount of $500 each will be granted to Advanced Trainees, clinical nurses or allied
health professionals to attend the inaugural Australian Lung Cancer Conference, hosted by the Australian Lung
Foundation on 30 June-2 July 2006 in Cairns, Queensland. Four similar awards are being offered in the names
of the four founding sponsors of the Australian Lung Foundation’s Lung Cancer Consultative Group: Sanofi
Aventis Award ($500), Eli Lilly Award ($500), AstraZeneca Award ($500), and Bristol-Myers Squibb Award
($500). Each award will also include complimentary delegate registration to the Conference.
The awards are open to Advanced Trainees, registered clinical nurses and allied health professional working at
any recognized Australian health care facility.
Priority will be given to those submitting ...
[127]
13492 Lung Cancer
[55,7 KB]
From [www.mariekeating.com] Last viewed: 07.09.2006
Lung Cancer Information
The Marie Keating Foundation has been established to provide cancer
information and awareness free of charge to general public throughout
Ireland. Our Units carry information on Breast, Testicular, Prostate,
Bowel, Lung , Skin and Cervical cancer . Our service is provided through
our registered Nurses on board the Units, leaflet information, teaching
aids, presentations, exhibitions and seminars.
The Marie Keating Foundation offers Medical and Nursing Scholarships.
Our future projects include Marie Keating Foundation waiting rooms
within Cancer Care Hospitals. As the Marie Keating Foundation is not
government funded we depend on private and corporate donations.
We at the Marie Keating Foundation would like to thank Breast Check,
The Irish Cancer Society, Action Cancer Northern Ireland, Cancer
Research UK and health care professionals specializing ...
[128]
Parliamentary Briefing - Lung Cancer Awareness Month
[59,1 KB]
From [www.rcn.org.uk] Last viewed: 07.09.2006
1
S2M-2003 Lung Cancer
Awareness Month
RCN SCOTLAND PARLIAMENTARY BRIEFING
Introduction
It is estimated that one in three
people in Scotland will develop
some form of cancer during their
lifetime. Lung cancer is the most
common form of cancer in Scotland
and smoking is its primary cause,
estimated to account for around
90% of all cases. If a person stops
smoking, the risk of lung cancer
goes down quite quickly. There is
also an increasing body of evidence
to show that passive smoking
increases the risk of lung disease
and cancer .
It also effects people disproportion-
ately in terms of social class, with
those from areas of high social
deprivation twice as likely to be
diagnosed with lung cancer as
those from the least deprived areas.
Those from less deprived areas are
also more likely ...
[129]
MEDIA ADVISORY LUNG CANCER ALLIANCE ENCOURAGED BY PLAN TO ...
[55,7 KB]
From [www.alcase.org] Last viewed: 07.09.2006
***MEDIA ADVISORY***
XYOTAX™ New Drug Application
On behalf of lung cancer patients, survivors, their caregivers, and those at risk for the disease, the
Lung Cancer Alliance is encouraged to learn of Cell Therapeutics Inc.’s (CTI) decision to submit a
new drug application (NDA) for XYOTAX to target survival in women with lung cancer .
“We applaud CTI for its interest in better understanding this devastating disease – since lung cancer
patients are faced with so few treatment options,” said Laurie Fenton, President of the Lung Cancer
Alliance. “While we recognize that there are many more steps to go in this process before we learn
for certain whether this drug will improve survival rates for women – we are heartened that CTI
would take such initiative. We will continue to monitor this research closely.”
Lung cancer will kill nearly twice as many women as breast cancer this year. More research ...
[130]
Lung Cancer Can Strike Nonsmokers
[38,0 KB]
From [www.dhs.ca.gov] Last viewed: 07.09.2006
Lung Cancer Can Strike Nonsmokers
Dana Reeve, widow of Christopher Reeve, highlights growing incidence of malignancy
unconnected to smoking
By Amanda Gardner
HealthDay Reporter
WEDNESDAY, Aug. 10 (HealthDay News) -- The news that Dana Reeve, the widow of
"Superman" actor Christopher Reeve, has lung cancer proves the disease can -- and does --
strike anyone.
She is only 44 years old. And never smoked.
Her revelation Tuesday followed by two days the lung - cancer death of ABC news anchor P
Jennings at age 67.
eter
Jennings was both a smoker and an ex-smoker: He quit for 20 years but admitted starting
again after the Sept. 11, 2001, terrorist attacks.
While Jennings' ordeal was probably due to cigarettes, Reeve's struggle is less understandable.
Some 85 percent to 90 percent of lung cancer cases occur in smokers, said Dr. Ruth Oratz, an associate professor
...
[131]
Lung Cancer in Women
[67,4 KB]
From [www.womenshealthpc.com] Last viewed: 07.09.2006
WOMEN’S HEALTH in Primary Care
Vol. 8, No. 3/APRIL 2005
149
T
he American Cancer Society estimates that
about 46% of new lung cancers in 2005 will
be in women
1
—a statistic that seems unre-
markable until one considers that just 30
years ago the disease was more than three times as
common in men as in women. Yet although the de-
gree to which women have “caught up” to men in-
evitably inspires ironic references
to the old “You’ve come a long way,
baby” cigarette ad slogan, a recent
analysis of national epidemiologi-
cal data by Fu and colleagues
2
does reveal some mildly encourag-
ing trends regarding lung cancer in
women—depending on one’s per-
spective. Below, we examine some
of these trends, from both a glass-
half-empty and a glass-half-full
point of view.
L
UNG CANCER INCIDENCE
...
[132]
Attention Scientists: New Lung Cancer Treatment Needed
[606,4 KB]
From [mrsec.wisc.edu] Last viewed: 07.09.2006
MRSEC
The Internships in Public Science Education program ( ipse@chem.wisc.edu ) is funded by a grant from the National
Science Foundation. This program is a collaboration between the University of Wisconsin Materials Research Science and
Engineering Center on Nanostructured Materials and Interfaces and the James Lovell Museum of Science, Economics &
Technology in Milwaukee, Wisconsin All materials are copyright © 2002 The Board of Regents of the University of
Wisconsin System.
Attention Scientists: New Lung
Cancer Treatment Needed
A patient has lung cancer and she has tried various treatments to cure her cancer including
chemotherapy and homeopathic therapies. Her cancer is very resistant to traditional treatments. A
new cancer drug has been developed and looks very promising for curing lung cancer resistant to
current treatments. However, this drug is very harmful to many ...
[133]
Lung cancer where to start sheet
[33,1 KB]
From [www.ottawahospital.on.ca] Last viewed: 07.09.2006
Where to Start Sources of Information on Lung Cancer
Suggestions for resources when you begin to look for
information about lung cancer .
Prepared by the Ninon Bourque Patient Resource Library
The Ottawa Hospital Regional Cancer Centre
501 Smyth Road, Ottawa, ON, K1H 8L6
613-737-7700 ext 70107
These resources are provided for information purposes only and are not intended as a substitute for
medical care. Inclusion of a resource does not imply endorsement by The Ottawa Hospital. If you
have any questions about your healthcare, please consult your healthcare provider.
If you would like to have more information about this topic, please contact the Ninon Bourque Patient
Resource Library at 613-737-7700 ext. 70107 or consumerhealth@ottawahospital.on.ca .
Brochure
Lung cancer : what you need to know .
An 11-page booklet providing information about lung cancer ...
[134]
The Impact of PET on the Management of Lung Cancer: The Referring ...
[84,4 KB]
From [www.stanfordhospital.com] Last viewed: 07.09.2006
The Impact of PET on the Management of Lung
Cancer : The Referring Physician’s Perspective
Marc A. Seltzer, MD
1
; Cecelia S. Yap, BS
1
; Daniel H. Silverman, MD, PhD
1
; Joubin Meta, BS
1
;
Christiaan Schiepers, MD, PhD
1
; Michael E. Phelps, PhD
1
; Sanjiv S. Gambhir, MD, PhD
1
; Jyotsna Rao, MD
2
;
Peter E. Valk, MD
2
; and Johannes Czernin, MD
1
1
Department of Molecular and Medical Pharmacology, Ahmanson Biological Imaging Clinic/Nuclear Medicine,
UCLA School of Medicine, Los Angeles, California; and
2
Northern California PET Imaging Center, Sacramento, California
18
F-FDG PET is a molecular whole-body imaging modality that
is increasingly being used for diagnosing, staging, and restaging
cancer . The ...
[135]
072700 Preoperative Staging of NonSmall-Cell Lung Cancer
[254,5 KB]
From [www.stanfordhospital.com] Last viewed: 07.09.2006
254
· July 27, 2000
The New England Journal of Medicine
PREOPERATIVE STAGING OF NON–SMALL-CELL LUNG CANCER
WITH POSITRON-EMISSION TOMOGRAPHY
R
EMGE
M. P
IETERMAN
, M.D., J
OHN
W.G.
VAN
P
UTTEN
, M.D., J
ACOBUS
J. M
EUZELAAR
, M.D., E
DUARD
L. M
OOYAART
, M.D.,
W
ILLEM
V
AALBURG
, P
H
.D., G
ERARD
H. K
OËTER
, M.D., V
ACLAV
F
IDLER
, P
H
.D., J
AN
P
RUIM
, M.D.,
AND
H
ARRY
J.M. G
ROEN
, M.D.
A
BSTRACT
Background
Determining the stage of non–small-
cell lung cancer often requires ...
[136]
Lung Cancer and Exposure to Ionizing Radiation Summary Findings of ...
[38,4 KB]
From [www.jsi.com] Last viewed: 07.09.2006
Center for Environmental Health Studies
(617) 482-9485
44 Farnsworth Street, Boston, MA 02210
http://www.jsi.com
Lung Cancer and Exposure to Ionizing Radiation
1
Lung Cancer and
Exposure to Ionizing Radiation
Summary
:
Studies conducted at the Los Alamos National Laboratory and other nuclear facilities
suggest an increased likelihood of developing lung cancer for workers who have been exposed to ionizing
radiation. These findings are consistent with the determination of the National Research Council’s BEIR V
committee that lung tissue if sensitive to ionizing radiation. Lung cancer is a “specified” cancer under the
Energy Employees Occupational Illness Compensation Program Act. Historically, lung cancer incidence
and mortality ranked among the lowest in the state for both Los Alamos and Rio Arriba Counties.
Incidence means new cases of ...
[137]
Radon and Lung Cancer in New Hampshire
[768,6 KB]
From [www.cdc.gov] Last viewed: 07.09.2006
Radon and Lung Cancer
in New Hampshire
Making The Connection
Making The Connection
for Risk Communication
for Risk Communication
Megan Tehan, Epidemiologist
Megan Tehan, Epidemiologist
Matthew Cahillane, Program Manager
Matthew Cahillane, Program Manager
April 22, 2005
April 22, 2005
Page 2
Presentation Overview
What is radon?
What is radon?
What are its health effects?
What are its health effects?
Awareness, attitudes and actions of
Awareness, attitudes and actions of
NH citizens
NH citizens
Associating radon with lung cancer for
Associating radon with lung cancer for
better risk communication
better risk communication
Page 3
What is Radon?
Radioactive gas
Radioactive ...
[138]
Case report : pineal metastasis from lung cancer
[113,5 KB]
From [www.priory.com] Last viewed: 07.09.2006
Copyright Priory Lodge Education Ltd. 2005
First Published 17
th
June 2005
Case report : pineal metastasis from lung cancer
Dr. K.W. Lam
1
MRCS , Dr F C Cheung
2
FRCS , FHKAM , Dr K M Ko
1
FRCS , FHKAM
Department of Cardiothoracic Surgery
1
,Department of Neurosurgery
2
, Queen
Elizabeth Hospital, 30 Gascoigne Road, Hong Kong.
Correspondence :
Dr K.W. Lam , fax : 00852- 2958-5673 , email : pkwlam1@yahoo.com
Department of Cardiothoracic Surgery, Queen Elizabeth Hospital , 30 Gascoigne
Road, Kowloon, Hong Kong
Running title
Metastasis to the pineal gland from carcinoma of lung are rare.
2
This is a
case report of a 57 year old lady presented with progressive diplopia,
nausea and headache. CT brain revealed pineal metastasis from ...
[139]
NON-SMALL-CELL LUNG CANCER
[473,2 KB]
From [www.decisionresources.com] Last viewed: 07.09.2006
Pharmacor
NON-SMALL-CELL LUNG CANCER
Page 2
Non-Small-Cell Lung Cancer
Pharmacor
2
YOU NEED TO KNOW:
How are treatment paradigms evolving in non-small-cell lung cancer (NSCLC)? In light of
recent clinical trial evidence, what is the future of gefitinib in this market? How will novel
agents be incorporated into current treatment regimens?
INTRODUCTION:
The marketplace for therapies to treat NSCLC, one of the most common and deadly forms of
cancer , is undergoing rapid change. Our research has revealed three major forces that will
continue to drive market expansion: an increase in the number of patients deemed eligible
for chemotherapy; the rapid uptake of novel targeted therapies; and increasing use of
newer, branded agents in chemotherapy regimens. Despite recent advances in treatment,
however, NSCLC carries a huge burden ...
[140]
Lung Cancer
[45,5 KB]
From [www.preventcancer.org] Last viewed: 07.09.2006
Lung Cancer
Lung cancer is the leading cause of cancer deaths for both men and women — an
estimated 163,510 people will die of lung cancer in 2,005. But death rates are declining in
both men and women. Tobacco use is the most important risk factor for lung cancer .
PREVENTION
• Don’t use tobacco in any form.
• If you use tobacco, quit.
• Create smoke-free environments in your community.
RISK
• People who use tobacco in any form
• People who have had exposure to substances such as arsenic, radon and
asbestos
People whose occupation exposes them to radiation
• People exposed to second-hand smoke
• All people exposed to air pollution and environmental smoke
SYMPTOMS
In the early stages, there may be no symptoms. Later these signs may appear:
• Persistent cough
• Sputum (spit) streaked with blood
• Chest pain
• Recurring pneumonia or ...
[141]
TRENDS IN LUNG CANCER MORBIDITY AND MORTALITY AMERICAN LUNG ...
[93,8 KB]
From [www.lungusa.org] Last viewed: 07.09.2006
TRENDS IN LUNG CANCER MORBIDITY AND MORTALITY
AMERICAN LUNG ASSOCIATION
EPIDEMIOLOGY AND STATISTIC UNIT
RESEARCH AND PROGRAM SERVICES
MAY 2005
Page 2
TABLE OF CONTENTS
Trends in Lung Cancer Morbidity and Mortality
Introduction
Lung Cancer Mortality Trends, 1979-2002
Lung Cancer Incidence Trends, 1973-2002
Lung Cancer Trends in Hospital Discharges, 1979-2002
Lung Cancer Survival Rates Trends, 1960-2001
Lung Cancer Types and Stage Distribution, 1995-2001
Smoking-Attributable Lung Cancer Deaths, 1997-2001
Lifetime Risk of Being Diagnosed with and Dying from Lung Cancer , 2000-2002
References
List of Tables
Table 1: Lung Cancer : Number of Deaths By Race and Sex, 1979-1998, 1999-2002
Table 2: Lung Cancer : Age-Adjusted Mortality Rates By Race and Sex, 1979-1998, 1999-2002
Table 3: Lung ...
[142]
TRENDS IN LUNG CANCER MORBIDITYAND MORTALITY PART II GRAPHS ...
[76,2 KB]
From [www.lungusa.org] Last viewed: 07.09.2006
TRENDS IN LUNG CANCER MORBIDITYAND MORTALITY
PART II GRAPHS
AMERICAN LUNGASSOCIATION
EPIDEMIOLOGY & STATISTICS UNIT
RESEARCH AND PROGRAM SERVICES
MAY 2005
Page 2
30
35
40
45
50
55
60
65
Ag
e Ad
ju
st
ed
Deat
h
Rat
e
p
e
r 100,000 Perso
n
s
1940
2000
1979 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002
33.6
34.8
35.1
35.9
36.4
37.0
37.6
37.8
38.5
38.8
39.3
39.9
39.6
39.3
39.3
38.7
38.3
37.9
37.3
37.0
35.7
35.9
34.8
34.4
47.8
49.8
50.3
51.7
52.6
53.6
54.6
55.2
56.4
57.1
58.1
59.3
...
[143]
Lung Cancer from the Cancer Annual Report
[82,1 KB]
From [www.uchospitals.edu] Last viewed: 07.09.2006
MARK K. FERGUSON, M.D.
Professor, Cardiac & Thoracic Surgery
The Role of the Surgeon in Diagnosing
and Treating Lung Cancer
Since the first successful resections were performed for lung cancer 75 years ago, substantial progress has been made in
the surgical management of lung cancer . As a result, despite numerous advances in our understanding of the
pathobiology of this disease and the resultant development of therapies, surgery remains one of the mainstays of
curative therapy for lung cancer .
Techniques such as flexible fiberoptic bronchoscopy and sputum cytology remain the basic tools for lung cancer
diagnosis.Advances in radiology have led to the introduction of low dose helical computed tomography for screening
for lung cancer , which is effective in identifying small lung nodules not evident on plain chest radiographs. Such
nodules are not amenable to bronchoscopic biopsy, ...
[144]
Minimally Invasive Approaches to Surgery for Lung and Esophageal ...
[29,2 KB]
From [www.uchospitals.edu] Last viewed: 07.09.2006
7
Minimally Invasive Approaches to
Surgery for Lung and Esophageal
Cancer
Mark K. Ferguson, MD
Professor, Section of Cardiac and Thoracic Surgery
Department of Surgery
University of Chicago
(773) 702-3551
mferguso@surgery.bsd.uchicago.edu
Video-assisted thoracic surgery (VATS) was
introduced in the late 1980s to facilitate lung
biopsy, pleural procedures, and a variety of
other small operations that traditionally were
done through an open thoracotomy. Since then,
the scope of VATS has expanded to include
more major procedures such as resection of
mediastinal tumors, thoracic spine surgery,
and operations for benign esophageal disease.
During the past 5 years, a few pioneers have
used VATS techniques to perform lobectomy
and esophagectomy for cancer . These efforts
have been controversial because of concerns
over whether use of these ...
[145]
Facts on Smoking and Lung Cancer
[52,5 KB]
From [www.cancerwa.asn.au] Last viewed: 07.09.2006
Key statistics on smoking
•
Cigarette smoking remains the single largest
cause of preventable death and disease in
Australia.
Tobacco is a major risk factor for
several cancers, chronic obstructive pulmonary
disease, cardiovascular diseases, respiratory
diseases, asthma, low birth weight babies and
sudden infant death syndrome.
1
•
In Western Australia, the Department of Health
has estimated that in 2001, tobacco caused 1445
premature deaths from smoking-related illness.
2
It
is estimated that in 1998-1999, the direct and
indirect costs of tobacco use to the Western
Australian community were $1.6 billion.
3
•
Over the last 20 years, the prevalence of smoking
among adults in Western Australia decreased
from 32% in 1984 to around 19% in 2001.
4
•
Research shows that about a half of all persistent
...
[146]
Lung Cancer
[40,5 KB]
From [www.stlukesonline.org] Last viewed: 07.09.2006
Lung Cancer
When it comes to cancer , knowledge is good medicine.
More men and women die of lung cancer than any other type of cancer in the United States. In
recent years, more women have died from lung cancer than even breast cancer , because more
women continue to smoke.
Cigarette smoking is by far the most important preventable cause of lung cancer . Tobacco is
linked to 87 percent of all lung cancer cases. Other factors include exposure to:
• Industrial substances (such as chemicals and asbestos)
• Radiation exposure from occupational, medical and environmental sources
• Air pollution
• Radon exposure
People who smoke cigarettes and have exposure to other risk factors have an even greater
chance of developing cancer of the lung . Second-hand tobacco smoke increases lung cancer risk
for nonsmokers. The good news is studies show that after quitting, damaged lung tissue ...
[147]
Lung Cancer Summary, 2004
[187,4 KB]
From [dhfs.wisconsin.gov] Last viewed: 07.09.2006
1
LUNG CANCER SUMMARY
INTRODUCTION
WHO GETS LUNG CANCER ?
WHAT ARE THE MORTALITY AND SURVIVAL FIGURES FOR LUNG CANCER ?
HOW HAVE LUNG CANCER INCIDENCE AND MORTALITY CHANGED OVER TIME?
WHAT ARE THE RISK FACTORS FOR LUNG CANCER ?
HOW CAN LUNG CANCER BE PREVENTED OR CONTROLLED?
WHERE TO FIND MORE INFORMATION
DEFINITIONS
INTRODUCTION
More than 3,100 Wisconsin residents were diagnosed with lung cancer and 2,660 residents died
from lung cancer in 2000 (Table 1). Lung cancer is the second most common cancer among
women (second to breast cancer ) and men (second to prostate cancer ) and is the leading cause
of cancer deaths in Wisconsin. This paper summarizes information about primary lung cancer
incidence, mortality, risk factors, prevention and current research.
Table 1. Lung Cancer Incidence and ...
[148]
The Facts About Lung Cancer
[152,5 KB]
From [www.lungcanceralliance.org] Last viewed: 07.09.2006
888 16th Street NW
Suite 800
Washington DC 20006
202-463-2080
800-298-2436 hotline
lungcanceralliance.org
NO MORE EXCUSES. NO MORE LUNG CANCER .
Lung cancer is the leading cause of cancer death in the
United States.
Lung cancer causes 30% of all cancer deaths.
Lung cancer is the leading cancer killer among Caucasians,
African-Americans, Asians and Hispanic males.
Lung cancer will kill more people this year than:
• breast cancer
• prostate cancer
• colon cancer
• liver cancer
• kidney cancer
• melanoma combined
Lung cancer will kill 3 times as many men as prostate
cancer this year.
Lung cancer will kill nearly twice as many women as breast
cancer this year.
Over 50% of new lung cancer cases will be diagnosed at a
very late stage—Stage IIIb or IV—and only 5% of them will ...
[149]
Secondhand Smoke and Heart Disease, Lung Cancer, and Other Health ...
[882,2 KB]
From [www.hawaii.gov] Last viewed: 07.09.2006
•Secondhand smoke, also called Environmental Tobacco Smoke (ETS), is
recognized as the third preventable cause of death in the U.S., preceded
by active smoking and alcohol consumption. [1]
•Secondhand smoke exposure at home, work, or both combined is asso-
ciated with fatal coronary heart disease. [2] More than 35,000 heart
disease deaths can be attributed to secondhand smoke. [3]
•Annually secondhand smoke is responsible for an estimated 3000 lung
cancer deaths, 35,000 cardiovascular disease deaths, and 2,300 sudden
infant deaths. [4]
•The Environmental Protection Agency (EPA) estimates that annually, there
are 26,000 new cases of asthma in children and 300,000 cases of bronchi-
tis and pneumonia in children, which are directly attributable to second
hand smoke. [3]
•There is a high risk for heart disease for non-smokers married to a current
smoker. [2] Never smokers who are currently living with ...
[150]
Editorial Chemotherapy for Advanced Non-Small Cell Lung Cancer ...
[101,6 KB]
From [medind.nic.in] Last viewed: 07.09.2006
INDIAN JOURNAL OF MEDICAL & PAEDIATRIC ONCOLOGY
Vol. 26 No.1, 2005
3
Editorial
Approximately one third of all cancer -related
deaths are due to lung cancer , which accounts for
more deaths each year than breast, prostate, and
colon cancer combined. The median survival of
patients with untreated metastatic non–small-
cell lung cancer (NSCLC) is only four to five
months and one year survival rate is about 10
percent.
1
Chemotherapy for advanced NSCLC
cancer is often considered ineffective or
excessively toxic. However, meta-analysis has
demonstrated that compared to supportive care,
chemotherapy provides improvement in
survival in patients with advanced non–small-
cell lung cancer .
2
In addition, randomized
studies comparing chemotherapy with the “best
supportive care” have shown that chemotherapy
reduces symptoms ...